Confirming media reports, Baxter International announced it has agreed to sell its BioPharma Solutions (BPS) business to a private equity consortium of Warburg Pincus and...
19.04.2011
- Merck & Co., known as MSD outside the United States and Canada, announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00...
06.04.2011
- Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals for about $430 million to expand its ophthalmology business. Inspire's key product is...
